CTSOVSFHTX• 3 Months (Normalized)
CTSO vs FHTX (Cytosorbents Corporation vs Foghorn Therapeutics Inc.)
Showing Closing Date Range from Jul 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $3.97
+874.2%
Cytosorbents Corporation
Normalized Baseline0.00%
FHTX Performance $2
-66.67%
Foghorn Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+940.87 pts
CTSO outperforming by 940.87 percentage points
CTSOFHTX
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO FHTX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | CTSO Price | CTSO Gain (%) | FHTX Price | FHTX Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $3.97 | +874.20% | $2.00 | -66.67% | +940.87% |
| Oct 02, 2026 | $4.05 | +895.09% | $2.02 | -66.33% | +961.42% |
| Sep 30, 2026 | $3.90 | +858.23% | $- | - | |
| Sep 29, 2026 | $4.00 | +882.80% | $- | - | |
| Sep 28, 2026 | $4.02 | +887.71% | $- | - | |
| Sep 25, 2026 | $4.38 | +976.17% | $3.54 | -41.00% | +1017.17% |
| Sep 24, 2026 | $4.30 | +956.51% | $3.60 | -40.00% | +996.51% |
| Sep 23, 2026 | $4.91 | +1106.39% | $3.87 | -35.50% | +1141.89% |
| Sep 22, 2026 | $- | $4.24 | -29.33% | - | |
| Sep 21, 2026 | $5.51 | +1253.81% | $4.15 | -30.83% | +1284.64% |
| Sep 18, 2026 | $5.75 | +1312.78% | $4.14 | -31.00% | +1343.78% |
| Sep 17, 2026 | $5.76 | +1315.23% | $4.20 | -30.00% | +1345.23% |
| Sep 16, 2026 | $5.73 | +1307.86% | $4.17 | -30.50% | +1338.36% |
| Sep 15, 2026 | $6.06 | +1388.94% | $4.12 | -31.33% | +1420.27% |
| Sep 14, 2026 | $6.07 | +1391.40% | $4.36 | -27.33% | +1418.73% |
Page 1 of 5